Insmed公司董事长兼首席执行官William Lewis已正式披露其出售公司普通股的交易信息。完整备案文件可通过相关链接获取。
本次交易详情源自William Lewis的个人申报，作为公司高层持股变动的一部分，突显管理层股份调整动态。投资者可查阅官方文件以核实具体交易数据及背景。
免责声明：本资讯基于Insmed Inc.于2025年7月15日通过美国证券交易委员会EDGAR系统提交的原始备案生成（参考ID：0001104506-25-000030），仅供信息参考之用。内容不应被视为任何财务、投资或法律建议，Insmed Inc.对原始信息的准确性负全责。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.